Funds › AIGH Capital Management LLC
AIGH Capital Management LLC
13F for Q3 2026, filed Nov 2, 2026. 43 positions worth $991.8M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of AIGH Capital Management LLC in the latest 13F quarter?
Using 13F.ai, how has AIGH Capital Management LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of AIGH Capital Management LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | SNDK Sandisk Corporation | 94,000 | $163.5M | 16.5% | -36.9% | 13F ↗ |
| 2 | APPS Digital Turbine, Inc. | 6.55M | $72.7M | 7.3% | Unchanged | 13F ↗ |
| 3 | INTC Intel Corporation | 500,000 | $60.1M | 6.1% | -19.8% | 13F ↗ |
| 4 | MXL MaxLinear, Inc | 600,000 | $54.2M | 5.5% | -26.7% | 13F ↗ |
| 5 | SIMO Silicon Motion Technology Corporation · ADR | 164,000 | $45.9M | 4.6% | +13.9% | 13F ↗ |
| 6 | ASPN Aspen Aerogels, Inc. | 7.15M | $39.2M | 4.0% | New | 13F ↗ |
| 7 | CLFD Clearfield, Inc. | 1.22M | $37.9M | 3.8% | +20.7% | 13F ↗ |
| 8 | DDD 3D Systems Corporation | 8.12M | $29.2M | 2.9% | +11.7% | 13F ↗ |
| 9 | NNBR NN, Inc. | 7.53M | $27.6M | 2.8% | +65414% | 13F ↗ |
| 10 | MEI Methode Electronics, Inc. | 1.98M | $27.3M | 2.8% | +18.1% | 13F ↗ |
| 11 | FENC Fennec Pharmaceuticals Inc. | 2.50M | $26.6M | 2.7% | +0.5% | 13F ↗ |
| 12 | KIDS OrthoPediatrics Corp. | 1.17M | $26.1M | 2.6% | +334% | 13F ↗ |
| 13 | KYTX Kyverna Therapeutics, Inc. | 3.65M | $24.8M | 2.5% | +30.6% | 13F ↗ |
| 14 | ASYS Amtech Systems, Inc. | 1.25M | $21.0M | 2.1% | Unchanged | 13F ↗ |
| 15 | BDSX Biodesix, Inc. | 686,021 | $20.5M | 2.1% | +1.1% | 13F ↗ |
| 16 | NYXH Nyxoah SA | 14.63M | $20.2M | 2.0% | +0.7% | 13F ↗ |
| 17 | VUZI Vuzix Corporation | 6.75M | $18.8M | 1.9% | Unchanged | 13F ↗ |
| 18 | FOCL Edap Tms S A · ADR | 3.49M | $15.6M | 1.6% | New | 13F ↗ |
| 19 | ABEO Abeona Therapeutics Inc. | 2.90M | $15.2M | 1.5% | -2.9% | 13F ↗ |
| 20 | SOPH SOPHiA GENETICS SA | 1.69M | $14.2M | 1.4% | -57.3% | 13F ↗ |
| 21 | CEPL Capstone Energy Plus, Inc. | 2.92M | $13.1M | 1.3% | New | 13F ↗ |
| 22 | OESX Orion Energy Systems, Inc. | 407,000 | $12.4M | 1.3% | New | 13F ↗ |
| 23 | SPRB Spruce Biosciences, Inc. | 250,000 | $12.1M | 1.2% | Unchanged | 13F ↗ |
| 24 | VNDA Vanda Pharmaceuticals Inc. | 2.25M | $11.0M | 1.1% | +10.1% | 13F ↗ |
| 25 | VSTM Verastem, Inc. | 1.12M | $9.0M | 0.9% | -41.8% | 13F ↗ |
| 26 | RNXT RenovoRx, Inc. | 4.26M | $6.7M | 0.7% | -3.2% | 13F ↗ |
| 27 | PYPD PolyPid Ltd. | 1.25M | $6.6M | 0.7% | -17.1% | 13F ↗ |
| 28 | LRMR Larimar Therapeutics, Inc. | 1.85M | $5.9M | 0.6% | New | 13F ↗ |
| 29 | PTHS Pelthos Therapeutics Inc. | 256,012 | $5.4M | 0.5% | -22.2% | 13F ↗ |
| 30 | ADCT ADC Therapeutics SA | 4.32M | $5.3M | 0.5% | New | 13F ↗ |
| 31 | TLPH Talphera, Inc. | 4.29M | $5.0M | 0.5% | -6.8% | 13F ↗ |
| 32 | LIDR AEye, Inc. | 3.85M | $4.6M | 0.5% | Unchanged | 13F ↗ |
| 33 | NRXS Neuraxis, Inc. | 540,292 | $4.0M | 0.4% | +3.9% | 13F ↗ |
| 34 | COYA Coya Therapeutics, Inc. | 631,912 | $3.2M | 0.3% | Unchanged | 13F ↗ |
| 35 | IPWR Ideal Power Inc. | 780,486 | $3.1M | 0.3% | -12.8% | 13F ↗ |
| 36 | APYX Apyx Medical Corporation | 1.13M | $2.8M | 0.3% | Unchanged | 13F ↗ |
| 37 | WATT Energous Corporation | 182,000 | $2.4M | 0.2% | Unchanged | 13F ↗ |
| 38 | ELUT Elutia, Inc. | 2.53M | $2.0M | 0.2% | -6.1% | 13F ↗ |
| 39 | BNGO Bionano Genomics, Inc. | 1.17M | $1.8M | 0.2% | New | 13F ↗ |
| 40 | BFRI Biofrontera Inc. | 1.50M | $1.6M | 0.2% | +102% | 13F ↗ |
| 41 | QNRX Quoin Pharmaceuticals, Ltd. · ADR | 236,234 | $1.1M | 0.1% | +237% | 13F ↗ |
| 42 | APRE Aprea Therapeutics, Inc. | 1.02M | $761.7K | 0.1% | Unchanged | 13F ↗ |
| 43 | CRDL Cardiol Therapeutics Inc. | 100,000 | $166.0K | <0.1% | New | 13F ↗ |
Changes since Q2 2026
8 new, 14 added to, 12 trimmed, 7 exited, 9 unchanged. By estimated dollars.
New positions (8)
| ASPN Aspen Aerogels, Inc. | 7.15M | New | $39.2M |
| FOCL Edap Tms S A · ADR | 3.49M | New | $15.6M |
| CEPL Capstone Energy Plus, Inc. | 2.92M | New | $13.1M |
| OESX Orion Energy Systems, Inc. | 407,000 | New | $12.4M |
| LRMR Larimar Therapeutics, Inc. | 1.85M | New | $5.9M |
| ADCT ADC Therapeutics SA | 4.32M | New | $5.3M |
| BNGO Bionano Genomics, Inc. | 1.17M | New | $1.8M |
| CRDL Cardiol Therapeutics Inc. | 100,000 | New | $166.0K |
Added to (14)
| NNBR NN, Inc. | 7.53M | +65414% | $27.6M |
| KIDS OrthoPediatrics Corp. | 1.17M | +334% | $20.1M |
| CLFD Clearfield, Inc. | 1.22M | +20.7% | $6.5M |
| KYTX Kyverna Therapeutics, Inc. | 3.65M | +30.6% | $5.8M |
| SIMO Silicon Motion Technology Corporation · ADR | 164,000 | +13.9% | $5.6M |
| MEI Methode Electronics, Inc. | 1.98M | +18.1% | $4.2M |
| DDD 3D Systems Corporation | 8.12M | +11.7% | $3.1M |
| VNDA Vanda Pharmaceuticals Inc. | 2.25M | +10.1% | $1.0M |
| BFRI Biofrontera Inc. | 1.50M | +102% | $817.2K |
| QNRX Quoin Pharmaceuticals, Ltd. · ADR | 236,234 | +237% | $758.0K |
Trimmed (12)
| SNDK Sandisk Corporation | 94,000 | -36.9% | -$95.7M |
| MXL MaxLinear, Inc | 600,000 | -26.7% | -$19.7M |
| SOPH SOPHiA GENETICS SA | 1.69M | -57.3% | -$19.0M |
| INTC Intel Corporation | 500,000 | -19.8% | -$14.8M |
| VSTM Verastem, Inc. | 1.12M | -41.8% | -$6.5M |
| PTHS Pelthos Therapeutics Inc. | 256,012 | -22.2% | -$1.5M |
| PYPD PolyPid Ltd. | 1.25M | -17.1% | -$1.4M |
| ABEO Abeona Therapeutics Inc. | 2.90M | -2.9% | -$456.8K |
| IPWR Ideal Power Inc. | 780,486 | -12.8% | -$449.0K |
| TLPH Talphera, Inc. | 4.29M | -6.8% | -$365.4K |
Exited (7)
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 2, 2026 | 13F-HR | 44 | $991.8M | Current | SEC ↗ |
| Q2 2026 | Aug 7, 2026 | 13F-HR | 45 | $1.6B | Current | SEC ↗ |
| Q1 2026 | Apr 30, 2026 | 13F-HR | 43 | $733.2M | Current | SEC ↗ |
| Q4 2025 | Feb 2, 2026 | 13F-HR | 34 | $413.1M | Current | SEC ↗ |
| Q3 2025 | Oct 31, 2025 | 13F-HR | 38 | $354.9M | Current | SEC ↗ |
| Q2 2025 | Jul 29, 2025 | 13F-HR | 35 | $222.3M | Current | SEC ↗ |
| Q1 2025 | May 6, 2025 | 13F-HR | 41 | $241.6M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer